PERCHERON THERAPEUTICS LIMITED - News & Media

Market Cap $9.786M Add to my watchlist

Healthcare Biotechnology

Percheron Therapeutics Limited, formerly Antisense Therapeutics Limited, is a... Percheron Therapeutics Limited, formerly Antisense Therapeutics Limited, is a biotechnology company. The Company is engaged in developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The Company’s products include ATL1102 for Duchenne muscular dystrophy (DMD), ATL1103 for Acromegaly, and ATL1102 for Multiple Sclerosis (MS). ATL1102, is an antisense inhibitor targeting very late antigen 4 (VLA-4), an immune cell molecule. ATL1103 is a second-generation antisense drug designed to block growth hormone receptor (GHr) expression thereby reducing levels of the hormone insulin-like growth factor-I (IGF-I) in the blood and is a potential treatment for diseases associated with excessive growth hormone action. By inhibiting GHr production, ATL1103 in turn reduces IGF-I levels in the blood (serum). The Company is conducting a Phase II clinical trial of ATL1102 in DMD patients.More

RCE'S BREAKTHROUGH

Recce Pharmaceuticals (ASX:RCE) receives Indonesian approval for Phase 3 diabetic foot infection trial.

Articles & Videos

Percheron Therapeutics lays out expected timeline for avicursen trial data

Percheron expects to deliver topline data from its Duchenne muscular dystrophy (DMD) trial using avicursen from December 16.

02 Dec 2024 09:41 (AEDT)

(20min delay)
Last 0.9¢		Change 0.001(12.5%)		Mkt cap ! $9.786M

Open	High	Low	Value	Volume
0.8¢	0.9¢	0.8¢	$77.96K	9.168M

Buyers (Bids)

No.	Vol.	Price($)
30	24334462	0.8¢

Sellers (Offers)

Price($)	Vol.	No.
0.9¢	9371709	13

View Market Depth

No.	Vol.	Price($)
28	24334502	0.008
35	21071153	0.007
43	21781613	0.006
28	24024983	0.005
9	5286250	0.004

Price($)	Vol.	No.
0.009	9371769	13
0.010	15007448	17
0.011	7319042	9
0.012	9099622	10
0.013	746425	5

Last trade - 15.51pm 15/01/2025 (20 minute delay)


Last 0.9¢		Change 0.001 ( 12.5 %)
Open	High	Low	Volume
0.9¢	0.9¢	0.8¢	11864927
Last updated 15.58pm 15/01/2025 ?

PER (ASX) Chart